The molecular detection of circulating tumour cells

British Journal of Cancer

Volumn 72, Issue 2, 1995, Pages 268-276

  Johnson, P W M ^a   Burchill, S A ^a   Selby, P J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Minimal residual disease; Molecular diagnostics; Polymerase chain reaction; Reverse transcription

Indexed keywords

RETINOIC ACID RECEPTOR; RNA;

BLOOD; DNA SEQUENCE; EWING SARCOMA; GENE REARRANGEMENT; GENE TRANSLOCATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MOLECULAR BIOLOGY; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOLID TUMOR; T LYMPHOCYTE RECEPTOR GENE; TUMOR CELL;

HUMAN; NEOPLASM CIRCULATING CELLS; NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0029156960     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.324     Document Type: Article

References (126)

1. ALKAN S, ROSS CW, SIDDIQUI J, SHELDON S AND HANSON CA. (1993). Polymerase chain reaction (PCR) detection of myl/rar- alpha in acute promyelocytic leukemia (APL) using nested primers. Lab. Invest., 68, 1.
2. ALLIERI MA, FABREGA S, OZSAHIN H, DOUAY L, BARBU V AND GORIN NC. (1992). Detection of bcr/abl translocation by polymerase chain reaction in leukemic progenitor cells (ALL-cfu) from patients with acute lymphoblastic leukemia (ALL). Exp. Hematol., 20, 312-314.
3. ALMOGUERA C, SHIBATA D, FORRESTER K, MARTIN J, ARNHEIM H AND PERUCHO M. (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes. Cell, 53, 549-554.
4. ASTER JC, KOBAYASHI Y, SHIOTA M, MORI S AND SKLAR J.(1992). Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am. J. Pathol., 141, 291-299.
5. BAKSHI A, WRIGHT JJ, GRANINGER W, SETO M, OWENS J, COSSMAN J, JENSEN JP, GOLDMAN P AND KORSMEYER SJ. (1987). Mechanism of the t(14; 18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners. Proc. Natl Acad. Sci. USA, 84, 2396-2400.
6. BARON BW, NUCIFORA G, MCCABE N, ESPINOSA R AND LEBEAU MM. (1993). Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22) (q27;qll) in B-cell lymphomas. Proc. Natl Acad. Sci. USA, 90, 5262-5266.
7. BIONDI A, RAMBALDI A, PANDOLFI PP, ROSSI V, GIUDICI G, ALCALAY M, LOCOCO F, DIVERIO D, POGLIANI EM AND LANZI EM. (1992). Molecular monitoring of the myl retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood, 80, 492-497.
8. BIRD JM, BLOXHAM D, SAMSON D, MARCUS RE, RUSSELL NH, KELSEY SM, NEWLAND AC AND APPERLEY JF. (1994). Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br. J. Haematol., 88, 110-116.
9. BOON T, DE PLAEN E, LURQUIN C, VAN DEN EYNDE B, VAN DER BRUGGEN P, TRAVERSARI C, AMAR CA AND VAN PEL A.(1992). Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surveys, 13, 23-37.
10. BRISCO MJ, CONDON J, HUGHES E, NEOH SH, NICHOLSON I, SYKES PJ, TAURO G, EKERT H, WATERS K AND TOOGOOD I.(1993). Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Leukemia, 7, 1514-1520.
11. BRISCO MJ, CONDON J, HUGHES E, NEOH SH, SYKES PJ, SESHA-DRI R, TOOGOOD I, WATERS K, TAURO G AND EKERT H.(1994). Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
12. BURCHILL SA, BRADBURY FM, SELBY P AND LEWIS IJ. (1994b). Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur. J. Cancer (in press).
13. BURCHILL SA, BRADBURY FM, SMITH B, LEWIS IJ AND SELBY P. (1994a). Neuroblastoma cell detection by reverse transcriptase polymerase chain reaction (rt-PCR) for tyrosine hydroxylase messenger RNA. Int. J. Cancer, 57, 671-675.
14. BURCHILL SA, BRADBURY MF, PITTMAN K, SOUTHGATE J, SMITH B AND SELBY P. (1994c). Detection of epithelial cancer cells in peripheral blood by reverse transcriptase polymerase chain reaction. Br. J. Cancer, 71, 278-281.
15. CARELLA AM, PODESTA M, FRASSONI F, RAFFO MR, POLLICARDO N, PUNGOLINO E, VIMERCATI R, SESSAREGO M, PARODI C AND RABITTI C. (1993). Collection of normal blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Tranplant., 12, 267-271.
16. CASTAIGNE S, BALITRAND N, DETHE H, DEJEAN A, DEGOS L AND CHOMIENNE C. (1992). A pml retinoic acid receptor-alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood, 79, 3110-3115.
17. CAVE H, GUIDAL C, ROHRLICH P, DELFAU MH, BROYART A, LESCOEUR B, RAHIMY C, FENNETEAU O, MONPLAISIR N AND DAURIOL L. (1994). Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta-T-cell and gamma-T-cell receptor genes. Blood, 83, 1892-1902.
18. CHANG KS, LU JF, WANG G, TRUJILLO JM, ESTEY E, CORK A, CHU DT, FREIREICH EJ AND STASS SA. (1992). The t(15;17) breakpoint in acute promyelocytic leukemia cluster within 2 different sites of the myl gene targets for the detection of minimal residual disease by the polymerase chain reaction. Blood, 79, 554-558.
19. CHEN Q, YANG CYC, TSAN JT, XIA Y, RAGAB AH, PEIPER SC, CARROLL A AND BAER R. (1990). Coding sequences of the Tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J. Exp. Med., 172, 1403-1408.
20. CHEN SJ, CHEN Z, CHEN A, TONG JH, DONG S, WANG ZY, WAXMAN S AND ZELENT A. (1992). Occurrence of distinct pml rar-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase polymerase chain reaction. Oncogene, 7, 1223-1232.
21. CLEARY ML, SMITH SD AND SKLAR J. (1986a). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immuno- globulin transcript resulting from the t(14;18) translocation. Cell, 47, 19-28.
22. CLEARY ML, GALILI N AND SKLAR J. (19866). Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J. Exp. Med., 164, 315-320.
23. COTE RJ, ROSEN PP, LESSER ML, OLD U AND OSBORNE MP. (1991). Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol., 9, 1749-1756.
24. COTTER F, PRICE C, ZUCCA E AND YOUNG BD. (1990). Direct sequence analysis of the 14q+ and 18q– chromosome junctions in follicular lymphoma. Blood, 76, 131-135.
25. COX AL, SKIPPER J, CHEN Y, HENDERSON RA, DARROW TL, SHABANOWITZ J, ENGELHARD VH, HUNT DF AND SLINGLUFF CL. (1994). Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719.
26. CRESCENZI M, SETO M, HERZIG GP, WEISS PD, GRIFFITH RC AND KORSMEYER SJ. (1988). Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc. Natl Acad. Sci. USA, 85, 4869-73.
27. CROSS NCP, FENG L, CHASE A, BUNGEY J, HUGHES TP AND GOLDMAN JM. (1993). Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936.
28. DATTA YH, ADAMS PT, DROBYSKI WR, ETHIER SP, TERRY VH AND ROTH MS. (1994). Sensitive detection of occult breast cancer by the reverse transcriptase polymerase chain reaction. J. Clin. Oncol., 12, 475-482.
29. DAUWERSE JG, WESSELS JW, GILES RH, WIEGANT J, VANDERREI-JDEN BA, FUGAZZA G, JUMELET EA, SMIT E, BAAS F, RAAP AK, HAGEMEIJER A, BEVERSTOCK GC, VANOMMEN GJB AND BREUNING MH. (1993). Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4. Eo. Hum. Mol. Genet., 2, 1527-1534.
30. DE THE H, CHOMIENNE C, LANOTTE M, DEGOS L AND DEJEAN A.(1990). The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature, 347, 558-561.
31. DEGUCHI T, DOI T, EHARA H, ITO S, TAKAHASHI Y, NISHINO Y, FUJIHIRO S, KAWAMURA T, KOMEDA H AND HORIE M. (1993). Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase polymerase chain reaction. Cancer Res., 53, 5350-5354.
32. DELAGE R, SOIFFIER DJ, DEAR K AND RITZ J. (1991). Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogenic bone marrow transplantation in chronic myelogenous leukemia. Blood, 78, 2759-2767.
33. DELATTRE O, ZUCMAN J, MELOT T, GARAU XS, ZUCKER JM, LENOIR GM, AMBROS PF, SHEER D, TURCCAREL C AND TRICHE TJ. (1994). The Ewing family of tumors - a subgroup of small round cell tumors defined by specific chimeric transcripts. N. Engl. J. Med., 331, 294-299.
34. DELSOL G, GATTER KC, STEIN H AND OTHERS (1984). Human lymphoid cells express epithelial membrane antigen: Implications for diagnosis of human neoplasms. Lancet, 2, 1124-1128.
35. DIVERIO D, PANDOLFI PP, BIONDI A, AWISATI G, PETTI MC, MANDELLI F, PELICCI PG AND LOCOCO F. (1993). Absence of reverse transcription polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood', 82, 3556-3559.
36. DOWNING JR, HEAD DR, CURCIOBRINT AM, HULSHOF MG, MOT-RONI TA, RAIMONDI SC, CARROLL AJ, DRABKIN HA, WILL-MAN C AND THEIL KS. (1993). An amll/eto fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8-21)(q22-q22) translocation. Blood, 81, 2860-2865.
37. DOWNING JR, HEAD D, RAIMONDI S, CARROLL AJ, CURCIOBRINT AM, MOTRONI TA, HULSHOF MG, PULLEN DJ AND DOMER PH. (1994). The der(ll)-encoded mll/af-4 fusion transcript is consistently detected in (4-ll)(q21-q23)-containing acute lymphoblastic leukemia. Blood’, 83, 330-335.
38. DREYFUS F, MELLE J, QUARRE MC AND PILLIER C. (1993). Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy. Br. J. Haematol., 85, 411-412.
39. EARLY BREAST CANCER TRIALISTS’ COLLABORATIVE GROUP.(1992). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet, 339, 1-15, 71-85.
40. FABREGA S, LAPORTE JP, GIARRATANA MC, DOUAY L, FOUILLARD L, DA WM, PERROT C, BARBU V AND GORIN NC. (1993). Polymerase chain reaction - a method for monitoring tumor cell purge by long-term culture in bcr abl positive acute lymphoblastic leukemia. Bone Marrow Transplant., 11, 169-173.
41. FINKE J, SLANINA J, LANGE W AND DOLKEN G. (1993). Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J. Clin. Oncol., 11, 1668-1673.
42. FUKUHARA T, HOOPER WC, BAYLIN SB, BENSON J, PRUCKLER J, OLSON AC, EVATT BL AND VOGLER WR. (1992). Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene - a new, sensitive approach to monitor tumor cells in acute myelogenous leukemia. Leukemia Res., 16, 1031-1040.
43. GABERT J, THURET I, LAFAGE M, CARCASSONNE Y, MARAN-CHINI D AND MANNONI P. (1989). Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone marrow transplantation. Lancet, 2, 1125-1127.
44. GERHARD M, JUHL H, KALTHOFF H, SCHREIBER HW, WAGENER C AND NEUMAIER M. (1994). Specific detection of carcinoem- bryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol., 12, 725-729.
45. GRIBBEN JG, FREEDMAN AS, NUEBERG D, ROY DC, BLAKE KW, WOO SD, GROSSBARD ML, RABINOWE SN, CORAL F, FREEMAN GJ, RITZ J AND NADLER LM. (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl J. Med., 325, 1525-1533.
46. GRIBBEN JG, NUEBERG D, FREEDMAN AS, GIMMI CD, PESEK KW, BARBER M, SAPORITO L, WOO SD, CORAL F AND SPECTOR N. (1993). Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood, 81, 3449-3457.
47. GRIBBEN JG, NEUBERG D, BARBER M, MOORE J, PESEK KW, FREEDMAN AS AND NADLER LM. (1994). Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predicitive for relapse than detection in bone marrow. Blood, 83, 3800-3807.
48. GROSSBARD ML, GRIBBEN JG, FREEDMAN AS, LAMBERT JM, KINSELLA J, RABINOWE SN, ELISEO L, TAYLOR JA, BLÄTTLER WA, EPSTEIN CL AND NADLER LM. (1993). Adjuvant immuno- toxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin’s lymphoma. Blood, 81, 2263-2271.
49. GU Y, NAKAMURA T, ALDER H, PRASAD R, CANAANI O, CIMINO G, CROCE CM AND CANAANI E. (1992). The t(14– 11) chromosome translocation of human acute leukemias fuses the all-1 gene, related to Drosophila trithorax, to the af-4 gene. Cell, 71, 701-708.
50. HARBECK N, UNTCH M, PACHE L AND EIERMANN W. (1994). Tumour cell detection in the bone marrow of breast cancer patients at primary therapy - results of a 3 year median follow- up. Br. J. Cancer, 69, 566-571.
51. HARDINGHAM JE, KOTASEK D, FARMER B, BUTLER RN, MI JX, SAGE RE AND DOBROVIC A. (1993). Immunobead PCR - a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res, 53, 3455-3458.
52. HEAD D, HULSHOF MG, CURCIOBRINT AM, MOTRONI TA, DOMER P AND DOWNING JR. (1994). Reverse transcription polymerase chain reaction (rt-PCR) for detection of t(4; 11) (q21q23) in acute lymphoblastic leukemia (ALL). J. Cell Biochem., S18A, 210-210.
53. HEYDERMAN E AND MCCARTNEY JC. (1985). Epithelial membrane antigen and lymphoid cells. Lancet, 1, 109.
54. HIDDEMANN W, UNTERHALT M, KOCH P, NAHLER M AND HERRMANN R. (1994). New aspects in the treatment of advanced low-grade non-Hodgkin’s lymphomas - prednimustine/mitox- antrone versus cyclophosphamide/vincristine/prednisone followed by interferon-alfa versus observation only - a preliminary update of the German low-grade lymphoma study group. Semin. Hematol., 31, 32-35.
55. HUANG W, SUN GL, LI XS, CAO Q, LU Y, JANG GS, ZHANG FQ, CHAI JR, WANG ZY AND WAXMAN S. (1993). Acute promyelocytic leukemia - clinical relevance of 2 major pml-rar-alpha isoforms and detection of minimal residual disease by retrotrans- criptase polymerase chain reaction to predict relapse. Blood, 82, 1264-1269.
56. HUGHES TP, MORGAN GJ, MARTIAT P AND GOLDMAN JM. (1991). Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood, 77, 874-878.
57. HUNGER SP, GALILI N, CARROLL AJ, CRIST WM, LINK MP AND CLEARY ML. (1991). The t(1; 19)(q23;p 13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemia. Blood, 77, 687-694.
58. ISRAELI RS, MILLER WH, SU SL, POWELL T, FAIR WR, SAMADI DS, HURYK RF, DEBLASIO A, EDWARDS ET, WISE GJ AND HESTON WDW. (1994). Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate- specific antigen-based assays. Cancer Res., 54, 6306-6310.
59. IZRAELI S, KOVAR H, GADNER H AND LION T. (1992). Unexpected heterogeneity in e2a/pbxl fusion messenger RNA detected by the polymerase chain reaction in pediatric patients with acute lymphoblastic leukemia. Blood, 80, 1413-1417.
60. JOHNSON PWM, PRICE CGA, SMITH T, COTTER FE, MEERABUX J, ROHATINER AZS, YOUNG BD AND LISTER TA. (1994). Detection of cells bearing the t(14;18) translocation following myeloab- lative treatment and autologous bone marrow transplantation for follicular lymphoma. J. Clin. Oncol., 12, 798-805.
61. KAWASAKI ES, CLARK SS, COYNE MY, SMITH SD, CHAMPLIN R, WITTE ON AND MCCORMICK FP. (1988). Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl Acad. Sci. USA, 85, 5698-5702.
62. KOZU T, MIYOSHI H, SHIMIZU K, MASEKI N, KANEKO Y, ASOU H, KAMADA N AND OHKI M. (1993). Junctions of the amll/mtg8 (eto) fusion are constant in t(8-21) acute myeloid leukemia detected by reverse transcription-polymerase chain reaction. Blood, 82, 1270-1276.
63. KUSEC R, LACZIKA K, KNOBL P, FRIEDL J, GREINIX H, KAHLS P, LINKESCH W, SCHWARZINGER I, MITTERBAUER G, PURT-SCHER B, HAAS OA, LECHNER K AND JAEGER U. (1994). Amll/eto fusion messenger RNA can be detected in remission blood samples of all patients with t(821) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia, 8, 735-739.
64. KWOK S, HIGUCHI R. (1989). Avoiding false positives with PCR. Nature, 339, 237-238.
65. LACZIKA K, MITTERBAUER G, KORNINGER L, KNOBL P, SCHWARZINGER I, KAPIOTIS S, HAAS OA, KYRLE PA, PONT J, & OEHLER L. (1994). Rapid achievement of pml-rar-alpha polymerase chain reaction (PCR) negativity by combined treatment with all-*/m?-retinoic acid and chemotherapy in acute promyelocytic leukemia - a pilot study. Leukemia, 8, 1-5.
66. LANGLANDS K, CRAIG JIO, ANTHONY RS AND PARKER AC.(1993). Clonal selection in acute lymphoblastic leukemia demonstrated by polymerase chain reaction analysis of immunoglobulin heavy-chain and T-cell receptor delta-chain rearrangements. Leukemia, 7, 1066-1070.
67. LEE MS, CHANG KS, CABANILLAS F, FREIREICH EJ, TRUJILLO JM AND STASS SA. (1987). Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science, 237, 175-178.
68. LIMPENS J, DE JONG D, VAN KRIEKEN JH, PRICE CG, YOUNG BD, van OMMEN GJ AND KLUIN PM. (1991). Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene, 6, 2271-6.
69. LIMPENS J, STAD R, DE VLAAM C, SCHUURING E, VAN KRIEKEN JH AND KLUIN PM. (1992). B-cells with the lymphoma associated translocation t(14;18) are present in the blood B-cells of normal individuals. Blood, 80 (Suppl. 1), 258a.
70. LINDEMANN F, SCHLIMOK G, DIRSCHEDL P, WITTE J AND RIETHMULLER G. (1992). Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet, 340, 685-689.
71. LOCOCO F, DIVERIO D, PANDOLFI PP, BIONDI A, ROSSI V, AWI-SATI G, RAMBALDI A, ARCESE W, PETTI MC AND MELONI G.(1992). Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet, 340, 1437-1438.
72. McGLAVE PB, DEFABRITIS P, DEISSEROTH A, GOLDMAN J, BARNETT M, REIFFERS J, SIMONSSON B, CARELLA A AND AEPPLI D. (1994). Autologous transplants for chronic myelogenous leukemia - results from 8 transplant groups. Lancet, 343, 1486-1488.
73. MANSI JL, EASTON D, BERGER U, GAZET J-C, FORD HT, DEARN-LEY D AND COOMBES RC. (1991). Bone marrow micrometas- tases in primary breast cancer: Prognostic significance after 6 years’ follow-up. Eur. J. Cancer, 27, 1552-1555.
74. MATSUOKA A, MIYAMURA K, EMI N, TAHARA T, TANIMOTO M, NAOE T, OHNO R, KAKIZUKA A, EVANS RM AND SAITO H.(1993). Unexpected heterogeneity of pml/rar-alpha fused messenger RNA detected by nested polymerase chain reaction in acute promyelocytic leukemia. Leukemia, 7, 1151-1155.
75. MATTANO LA, MOSS TJ AND EMERSON SG. (1992). Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase polymerase chain reaction. Cancer Res., 52, 4701-4705.
76. MEIJERINK JPP, SMETSERS TFCM, RAEMAEKERS JMM, BOGMAN MJJT, DE WITTE T AND MENSINK EJBM. (1993). Quantitation of follicular non-Hodgkin’s lymphoma cells carrying t(14;18) by competitive polymerase chain reaction. Br. J. Haematol., 84, 250-256.
77. MILLER WH, KAKIZUKA A, FRANKEL SR, WARRELL RP, DE-BLASIO A, LEVINE K, EVANS RM AND DMITROVSKY E. (1992). Reverse transcription polymerase chain-reaction for the rearranged retinoic acid receptor-alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA, 89, 2694-2698.
78. MILLER WH, LEVINE K, DEBLASIO A, FRANKEL SR, DMITROVSKY E AND WARRELL RP. (1993). Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription-polymerase chain reaction assay for the pml rar-alpha fusion messenger RNA. Blood, 82, 1689-1694.
79. MIYAMURA K, TANIMOTO M, MORISHIMA Y, HORIBE K, YAMAMOTO K, AKATSUKA M, KODERA Y, KOJIMA S, MATSUYAMA K, HIRABAYASHI N, YAZAKI M, IMAI K, ONOZAWA Y, KANA- MARU A, MIZUTANI S AND SAITO H. (1992). Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction - possible eradication of minimal residual disease by marrow transplantation. Blood, 79, 1366-1370.
80. MOERTEL CG, FLEMING TR, MACDONALD JS, HALLER DG, LAURIE JA, GOODMAN PJ, UNGERLEIDER JS, EMERSON WA, TORMEY DC, GLICK JH, VEEDER MH AND MAILIARD JA.(1990). Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med., 322, 352-358.
81. MOLINO A, COLOMBATTI M, BONETTI F, ZARDINI M, PASINI F, PERINI A, PELOSI G, TRIDENTE G, VENERI D AND CETTO GL.(1991). A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer, 67, 1033-1036.
82. MOLL R, LOWE A, LÄUFER J AND FRANKE WW. (1992). Cyto- keratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am. J. Pathol., 140, 427-447.
83. MORENO JG, CROCE CM, FISCHER R, MONNE M, VIHKO P, MUL- HOLLAND SG AND GOMELLA LG. (1992). Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52, 6110-6112.
84. MORGAN GJ, HUGHES T, YANSSEN JWG, GOW J, GUO AP, GOLDMAN JM, WIEDEMANN LM AND BARTRAM CR. (1989). Polymerase chain reaction for detection of residual leukaemia. Lancet, 1, 928-930.
85. MORRIS SW, KIRSTEIN MN, VALENTINE MB, DITTMER KG, SHAPIRO DN, SALTMAN DL AND LOOK, AT. (1994). Fusion of a kinase gene, Aik, to a nucleolar protein gene, Npm, in non- Hodgkin’s lymphoma. Science, 263, 1281-1284.
86. NAGAFUJI K, HARADA M, TAKAMATSU Y, ETO T, TESHIMA T, KAMURA T, OKAMURA T, HAYASHI S, AKASHI K AND MURA- KAWA M. (1993). Evaluation of leukemic contamination in peripheral blood stem cell harvests by reverse transcriptase polymerase chain reaction. Br. J. Haematol., 85, 578-583.
87. NAGLE, RB. (1988). Intermediate filaments: A review of basic biology. Am. J. Surg. Pathol., 12 (Suppl. 1), 4-16.
88. NAITO H, KUZUMAKI N, UCHINO J-I, KOBAYASHI R, SHIKANO T, ISHIKAWA Y AND MATSUMOTO S. (1991). Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur. J. Cancer, 27, 762-765.
89. NEALE GAM, MENARGUEZ J, KITCHINGMAN GR, FITZGERALD TJ, KOEHLER M, MIRRO JJ AND GOORHA RM. (1991). Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood, 78, 739-744.
90. NEGRIN RS AND PESANDO J. (1994). Detection of tumor cells in purged bone marrow and peripheral blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J. Clin. Oncol., 12, 1021-1027.
91. NIZET Y, VANDAELE S, LEWALLE P, VAERMAN JL, PHILIPPE M, VERMYLEN C, CORNU G, FERRANT A, MICHAUX JL AND MARTIAT P. (1993). Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood, 82, 1618-1625.
92. NORRIS MD, GILBERT J, MARSHALL GM AND HABER M. (1994). Detection of minimal residual neuroblastoma by reverse transcription polymerase chain reaction. Proc. Am. Assoc. Cancer Res., 35, 1218.
93. OSBORNE M, WONG GY, ASINA S, OLD U, COTE RJ AND ROSEN PP. (1991). Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res., 51, 2706-2709.
94. PELICCI PG, KNOWLES DM, MAGRATH I AND DALLA-FAVERA R.(1986). Chromosomal breakpoints and structural alterations of the c-Myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc. Natl Acad. Sci. USA, 83, 2984-2988.
95. PHILIP T, ARMITAGE JO, SPITZER G, CHAUVIN F, JAGANNATH S, CAHN J-Y, COLOMBAT P, GOLDSTONE AH, GORIN NC, FLESH M, LAPORTE J-P, MARANINCHI D, PICO J, BOSLY A, ANDERSON C, SCHOTS R, BIRON P, CABANILLAS F AND DICKE K.(1987). High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N. Engl. J. Med., 316, 1493-1498.
96. POTTER MN, STEWARD CG, MAITLAND NJ AND OAKHILL A. (1992). Detection of clonality in childhood B-lineage acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia, 6, 289-294.
97. PRICE CGA, MEERABUX J, MURTAGH S, COTTER FE, ROHATINER AZS, YOUNG BD AND LISTER TA. (1991a). The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J. Clin. Oncol., 9, 1527-1532.
98. PRICE CGA, ROHATINER AZS, STEWARD WP, DEAKIN DP, BAILEY N, NORTON A, BLACKLEDGE G, CROWTHER D AND LISTER TA. (19916). Interferon-a2b in the treatment of follicular lymphoma: Preliminary results of a trial in progress. Ann. Oncol., 2 (Suppl. 2), 141-145.
99. PRIVERITERA E, KAMPS MP, HAYASHI Y, INABA T, SHAPIRO LH, RAIMONDI SC, BEHM F, HENDERSHOT L, CARROLL AJ, BALTIMORE D AND LOOK AT. (1992). Different molecular consequences of the 1 19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood, 79, 1781-1788.
100. RIETHMULLER G, SCHNEIDERGADICKE E, SCHLIMOK G, SCHMIEGEL W, RAAB R, HOFFKEN K, GRUBER R, PICHLMAIER H, HIRCHE H AND PICHLMAYR R. (1994). Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet, 343, 1177-1183.
101. ROTH MS, ANTIN JH AND GINSBURG D. (1989). Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood, 77, 874.
102. SAIKI RK, BUGAWAN TL, HORN GT, MULLIS KB AND ERLICH HA. (1986). Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature, 324, 163-6.
103. SAVTCHENKO ES, SCHIFF TA, JIANG C-K, FREEDBURG IM AND BLUMENBURG M. (1988). Embryonic expression of the human 40-kD keratin: Evidence from a processed pseudogene sequence. Am. J. Hum. Genet., 43, 630-637.
104. SAWYERS CL, TIMSON L, KAWASAKI ES, CLARK SS, WITTE ON AND CHAMPLIN R. (1990). Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc. Natl Acad. Sci. USA, 87, 563-567.
105. SCHLIMOK G, FUNKE I, HOLZMANN B, GOTTLINGER G, SCHMIDT G, HAUSER H, SWIERKOT S, WARNECKE HH, SCHNEIDER B, KOPROWSKI H AND RIETHMULLER G. (1987). Micrometastatic cancer cells in bone marrow: In vitro detection with anti- cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc. Natl Acad. Sci. USA, 84, 8672-8676.
106. SCHOENFELD A, LUQMANI E, SMITH D, OREILLY S, SHOUSHA S, SINNET HD AND COOMBES RC. (1994). Detection of breast cancer micrometastases in axillary lymph-nodes by using polymerase chain reaction. Cancer Res., 54, 2986-2990.
107. SIDRANSKY D, TOKINO T, HAMILTON SR, KINZLER KW, LEVIN B, FROST P AND VOGELSTEIN B. (1992). Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science, 256, 102-105.
108. SMITH B, SELBY P, SOUTHGATE J, PITTMAN K, BRADLEY C AND BLAIR GE. (1991). Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet, 338, 1227-1229.
109. SOEKARMAN D, VONLINDERN M, VANDERPLAS DC, SELLERI L, BARTRAM CRI, MARTIAT P, CULLIGAN D, PADUA RA, HAS- PERVOOGT KP AND HAGEMEIJER A. (1992). Dek-can rearrangement in translocation (69)(p23 q34). Leukemia, 6, 489-494.
110. STEWARD CG, GOULDEN NJ, KATZ F, BAINES D, MARTIN PG, LANGLANDS K, POTTER MN, CHESSELLS JM, & OAKHILL A.(1994). A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta-gene rearrangements between presentation of childhood B-lineage acute lymphoblastic leukemia. Blood, 83, 1355-1362.
111. SWIRSKY DM, LI YS, MATTHEWS JG, FLEMANS RJ, REESE JKH AND HAYHOE FGJ. (1984). 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features. Br. J. Haematol, 56, 119-213.
112. TADA M, OMATA M, KAWAI S, SAISHO H, OHTO M, SAIKI RK AND SNINSKY JJ. (1993). Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res., 53, 2472-2474.
113. TAKVORIAN T, CANELLOS GP, RITZ J, FREEDMAN AS, ANDERSON KC, MAUCH P, TARBELL N, CORAL F, DALEY H, YEAP B, SCHLOSSMAN SF AND NADLER LM. (1987). Prolonged disease- free survival after autologous bone marrow transplantation in patients with non-Hodgkin’s lymphoma with a poor prognosis. N. Engl. J. Med., 316, 1499-1505.
114. TKACHUK DC, KOHLER S AND CLEARY ML. (1992). Involvement of a homolog of Drosophila trithorax by llq23 chromosomal translocations in acute leukemias. Cell., 71, 691-700.
115. TRAWEEK ST, LIU J AND BATTIFORA H. (1993). Keratin gene expression in nonepithelial tissues - detection with polymerase chain reaction. Am. J. Pathol., 142, 1111-1118.
116. UDOMSAKDI C, EAVES CJ, SWOLIN B, REID DS, BARNETT MJ AND EAVES AC. (1992). Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc. Natl Acad. Sci. USA, 89, 6192-6196.
117. VANRHEE F, LIN F, CULLIS JO, SPENCER A, CROSS NCP, CHASE A, GARICOCHEA B, BUNGEY J, BARRETT J AND GOLDMAN JM.(1994). Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant - the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377-3383.
118. VERES G, GIBBS RA, SCHERER SE AND CASKEY CT. (1987). The molecular basis of the sparse fur mutation. Science, 237, 415-417.
119. VOGELSTEIN B, FEARON ER, HAMILTON SR, KERN SE, PREIS- INGER AC, LEPPERT M, NAKAMURA Y, WHITE R, SMITS AMM AND BOS JL. (1988). Genetic alterations during colorectal tumor development. N. Engl. J. Med., 319, 525-532.
120. VORMWALD-DOGAN V, NICKEL P, WILLEMSE M, THOME M AND TILGEN W. (1994). Prevalence of melanoma cells in peripheral blood of patients with malignant-melanoma stage I-IV - detection by polymerase chain reaction. J. Invest. Dermatol, 103, 405-405.
121. WILLIAMS ME, SWERDLOW SH, ROSENBERG CL AND ARNOLD A. (1992). Characterization of chromosome 11 translocation breakpoints at the bcl-1 and Prad-1 loci in centrocytic lymphoma. Cancer Res., 52, 5541s-5544s.
122. YAMADA M, WASSERMAN R, LANGE B, REICHARD BA, WOMER RB AND ROVERA G. (1990). Minimal residual disease in childhood B-lineage lymphoblastic leukemia: Persistence of leukemic cells during the first 18 months of treatment. N. Engl. J. Med., 323, 448-455.
123. YAMAMOTO K, SETO M, IIDA S, KOMATSU H, KAMADA N, KOJIMA S, KODERA Y, NAKAZAWA S, SAITO H AND TAKAHASHI T.(1994). Reverse transcriptase polymerase chain reaction detects heterogeneous chimeric messenger RNAs in leukemias with llq23 abnormalities. Blood, 83, 2912-2921.
124. ZAKUT R, TOPALIAN SL, KAWAKAMI Y, MANCINI M, ELIYAHU S AND ROSENBERG SA. (1993). Differential expression of MAGE- 1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res., 53, 5-8.
125. ZOUBECK A, PFLEIDERER C, SALZER-KUNTSCHINK M, AMMAN G, WINDHAGER R, FINK FM, KOSCRELNIAK E, DELATTRE O, STREHL S, AMBROS PF, GADNER H AND KOVAR H. (1994). Variability of EWS chimaeric transcripts in Ewings tumors: A comparison of clinical and molecular data. Br. J. Cancer, 70, 908-913.
126. ZUCMAN J, DELATTRE O, DESMAZE C, PLOUGASTEL B, JOUBERT I, MELOT T, PETER M, DEJONG P, ROULEAU G AND AURIAS A.(1992). Cloning and characterization of the Ewing’s sarcoma and peripheral neuroepithelioma t(1122) translocation breakpoints. Genes Chrom. Cancer, 5, 271-277.